English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist

2.570
+0.060+2.39%

Close Jan 17 16:00 ET

2.550
-0.020-0.78%

Post 20:01 ET

275.04MMarket Cap-4.94P/E (TTM)

Aclaris Therapeutics News

News

Announcement

Ratings

All

Earnings

Transactions

Shareholding

Events

Other

Aclaris Therapeutics | 8-K: Current report
Jan 13 07:27 ET
Aclaris Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Dec 19, 2024 16:35 ET
Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nov 27, 2024 16:03 ET
Aclaris Therapeutics | 8-K: Current report
Nov 18, 2024 08:19 ET
Aclaris Therapeutics | 8-K: Current report
Jul 16, 2024 16:32 ET
Aclaris Therapeutics | 8-K: Current report
Jun 7, 2024 16:20 ET
Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
May 7, 2024 17:00 ET
Aclaris Therapeutics | DEFA14A: Others
Apr 25, 2024 07:05 ET
Aclaris Therapeutics | DEF 14A: Definitive information statements
Apr 25, 2024 07:05 ET
Aclaris Therapeutics | 8-K: Current report
Mar 19, 2024 16:33 ET
Aclaris Therapeutics | 8-K/A: Current report (Amendment)
Feb 5, 2024 16:36 ET
Aclaris Therapeutics | 8-K: Current report
Feb 5, 2024 16:35 ET
Aclaris Therapeutics | 8-K: Current report
Jan 19, 2024 00:00 ET
Aclaris Therapeutics | 8-K: Current report
Dec 19, 2023 16:15 ET
Aclaris Therapeutics | 8-K: Current report
Nov 13, 2023 07:42 ET
Aclaris Therapeutics | 8-K: Current report
Sep 18, 2023 08:00 ET
Aclaris Therapeutics | 8-K: Current report
Jun 12, 2023 16:15 ET
Aclaris Therapeutics | 8-K: Current report
Jun 2, 2023 16:05 ET
Aclaris Therapeutics | 8-K: Current report
Jun 1, 2023 16:18 ET
Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
May 8, 2023 16:05 ET

US

Overall

No Data